| 000 | 01231 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250517233432.0 | ||
| 264 | 0 | _c20191009 | |
| 008 | 201910s 0 0 eng d | ||
| 022 | _a1552-4604 | ||
| 024 | 7 |
_a10.1002/jcph.1290 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPang, Yinuo | |
| 245 | 0 | 0 |
_aAre Clinical Therapeutic Protein-Drug Interaction Studies Needed When Disease Modification Is Driving the Potential Interaction? _h[electronic resource] |
| 260 |
_bJournal of clinical pharmacology _c10 2018 |
||
| 300 |
_a1371-1372 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacokinetics |
| 650 | 0 | 4 |
_aCytokines _xgenetics |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation _xdrug therapy |
| 650 | 0 | 4 |
_aProteins _xmetabolism |
| 700 | 1 | _aRosebraugh, Matthew R | |
| 700 | 1 | _aFreise, Kevin J | |
| 700 | 1 | _aParikh, Apurvasena | |
| 700 | 1 | _aMohamed, Mohamed-Eslam F | |
| 773 | 0 |
_tJournal of clinical pharmacology _gvol. 58 _gno. 10 _gp. 1371-1372 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jcph.1290 _zAvailable from publisher's website |
| 999 |
_c28751505 _d28751505 |
||